These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8243609)

  • 1. Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562.
    Tosi P; Visani G; Ottaviani E; Gamberi B; Cenacchi A; Tura S
    Eur J Haematol; 1993 Oct; 51(4):209-13. PubMed ID: 8243609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea enhances 3'-azido-3'-deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models.
    Tosi P; Visani G; Ottaviani E; Tura S; Darnowski JW
    Eur J Haematol; 1994 May; 52(5):291-5. PubMed ID: 8020629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells.
    Darnowski JW; Davol PA; Goulette FA
    Biochem Pharmacol; 1997 Feb; 53(4):571-80. PubMed ID: 9105409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
    Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
    Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells.
    Berman E; Duigou-Osterndorf R; Krown SE; Fanucchi MP; Chou J; Hirsch MS; Clarkson BD; Chou TC
    Blood; 1989 Sep; 74(4):1281-6. PubMed ID: 2765664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
    Darnowski JW; Goulette FA
    Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
    Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R
    Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of in vitro treatment of chronic myelogenous leukemia cell line, K562 cells, using 4-hydroperoxycyclophosphamide, alpha-interferon and gamma-interferon.
    Lee JT; Park S; Lee JH; Kim BK; Kim NK
    J Korean Med Sci; 1996 Feb; 11(1):26-32. PubMed ID: 8703367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of 3'-azido-3'-deoxythymidine into cellular DNA and its removal in a human leukemic cell line.
    Vazquez-Padua MA; Starnes MC; Cheng YC
    Cancer Commun; 1990; 2(1):55-62. PubMed ID: 2369551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha enhances the cytotoxic and cytostatic activities of chemotherapeutic drugs in human myeloid leukemia cells.
    Hassan HT; Grell S; Borrmann-Danso U; Freund M
    J Interferon Cytokine Res; 1996 Feb; 16(2):139-46. PubMed ID: 8742366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic and biochemical implications of combining AZT and AG-331.
    Pressacco J; Mitrovski B; Erlichman C
    Cancer Chemother Pharmacol; 1995; 35(5):387-90. PubMed ID: 7850919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin and AZT synergistically inhibit the proliferation and induce the apoptosis of leukemia K562 cells through the EGR1 and the Wnt/β‑catenin pathway.
    Ma W; Liu F; Yuan L; Zhao C; Chen C
    Oncol Rep; 2020 Jan; 43(1):260-269. PubMed ID: 31746437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
    Chandrasekaran B; Kute TE; Duch DS
    Cancer Chemother Pharmacol; 1995; 35(6):489-95. PubMed ID: 7882457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
    Robak T; Korycka A
    Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-alpha, TNF, and quercetin): its application to autologous bone marrow transplantation for CML.
    Osman Y; Moriyama Y; Shibata A
    Exp Hematol; 1995 May; 23(5):444-52. PubMed ID: 7720816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.
    Pressacco J; Erlichman C
    Biochem Pharmacol; 1993 Dec; 46(11):1989-97. PubMed ID: 8267649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
    Zhen YS; Taniki T; Weber G
    Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia.
    Estrov Z; Talpaz M; Chou TC; Kurzrock R; Blake M; Gutterman JU
    Leukemia; 1991 Feb; 5(2):101-7. PubMed ID: 2020193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
    Weber G; Nagai M; Prajda N; Nakamura H; Szekeres T; Olah E
    Cancer Commun; 1991 Apr; 3(4):127-32. PubMed ID: 2025497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.